+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

RNA Vaccine Patent Landscape 2021 - Product Thumbnail Image

RNA Vaccine Patent Landscape 2021

  • Report
  • January 2021
  • 109 Pages
  • Global
Leukemia Therapeutics Market Report 2025 - Product Thumbnail Image

Leukemia Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025 - Product Thumbnail Image

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Prostate Health - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Prostate Health - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 119 Pages
  • Global
From
Acute Myeloid Leukemia Market Report 2025 - Product Thumbnail Image

Acute Myeloid Leukemia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Huntington Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Huntington Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 299 Pages
  • Global
From
Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032 - Product Thumbnail Image

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

  • Report
  • February 2022
  • 421 Pages
  • Global
From
Atrial Fibrillation - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Atrial Fibrillation - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 929 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 672 Pages
  • Global
From
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 1079 Pages
  • Global
From
Acute Myeloid Leukemia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Thumbnail Image

Acute Myeloid Leukemia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • February 2024
  • 137 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028

  • Report
  • October 2024
  • 126 Pages
  • Asia Pacific
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2025

  • Report
  • May 2025
  • 450 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sodium-dependent Glucose Co-transporter 2 (SGLT 2) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Sodium-dependent Glucose Co-transporter 2 (SGLT 2) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 100 Pages
  • Global
From
Schistosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Schistosomiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 40 Pages
  • Global
From
Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 74 Pages
  • Global
From
Immunology Market 2024-2028 - Product Thumbnail Image

Immunology Market 2024-2028

  • Report
  • August 2024
  • 176 Pages
  • Global
From
Loading Indicator